Randomized, placebo-controlled, double-blind study to evaluate the efficacy of 2LHERP® in patients with recurrent genital herpes infections.

Authors
Category Primary study
Registry of TrialsEU Clinical Trials Register
Year 2020
This article has no abstract
Epistemonikos ID: 57c41a2a3dbf91e1927bfa283a0c5d6d6fccb86a
First added on: Jan 23, 2025